Data / Drug companies / Bills Biotech Private Limited
Bills Biotech Private Limited: 19 products in the FDA NDC directory, labeler code 85941
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Bills Biotech Private Limited (labeler code 85941) lists 19 products in the FDA National Drug Code Directory. By type: 19 bulk ingredients. Its main marketing category is bulk ingredients for compounding. The newest product started marketing on October 26, 2026.
The request: Watch Bills Biotech Private Limited (FDA labeler code 85941): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 85941
- Products in commercial distribution
- 19
- Packages
- 129
- Finished drugs by generic name
- 0
- Prescription products
- 0
- Over the counter products
- 0
- Started marketing in the last 12 months
- 16
- Earliest marketing start
- July 1, 2025
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Bulk ingredients for compounding | 14 | 73.7% |
| Bulk ingredients | 5 | 26.3% |
Products by type
| Type | Products | Share |
|---|---|---|
| Bulk ingredients | 19 | 100% |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Powder | 19 | 100% |
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Bremelanotide acetate | 85941-052 | Powder | Bulk ingredients for compounding | October 26, 2026 |
| Diethylstilbestrol | 85941-051 | Powder | Bulk ingredients | September 16, 2026 |
| Levamisole hydrochloride | 85941-050 | Powder | Bulk ingredients | September 16, 2026 |
| Levamisole hydrochloride | 85941-050 | Powder | Bulk ingredients | September 16, 2026 |
| Tolazoline hcl | 85941-033 | Powder | Bulk ingredients | July 24, 2026 |
| Enclomiphene citrate | 85941-007 | Powder | Bulk ingredients for compounding | April 1, 2026 |
| Vardenafil hydrochloride trihydrate | 85941-029 | Powder | Bulk ingredients for compounding | March 16, 2026 |
| Metronidazole benzoate | 85941-021 | Powder | Bulk ingredients for compounding | March 16, 2026 |
| Tb 500 fragment | 85941-018 | Powder | Bulk ingredients for compounding | February 23, 2026 |
| Semax acetate | 85941-016 | Powder | Bulk ingredients for compounding | February 23, 2026 |
| Selank acetate | 85941-015 | Powder | Bulk ingredients for compounding | February 23, 2026 |
| Clomiphene citrate | 85941-014 | Powder | Bulk ingredients for compounding | February 13, 2026 |
| Cidofovir dihydrate | 85941-012 | Powder | Bulk ingredients for compounding | November 13, 2025 |
| Cidofovir anhydrous | 85941-011 | Powder | Bulk ingredients for compounding | November 13, 2025 |
| Amlexanox | 85941-009 | Powder | Bulk ingredients for compounding | November 12, 2025 |
| Ivermectin | 85941-008 | Powder | Bulk ingredients for compounding | November 11, 2025 |
| Sermorelin acetate | 85941-013 | Powder | Bulk ingredients for compounding | July 22, 2025 |
| Semaglutide ih | 85941-001 | Powder | Bulk ingredients | July 21, 2025 |
| Aviptadil acetate | 85941-031 | Powder | Bulk ingredients for compounding | July 1, 2025 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.